Natural compounds often demonstrate promising experimental results. However, a laboratory observation is not equivalent to demonstrated clinical benefit.
Translational development needs reproducible preclinical evidence, appropriate exposure and formulation data, safety evaluation, fit-for-purpose models, and an explicit regulatory and clinical evidence plan.
Use this article as a discussion starter. Add verified references and Swalife-specific examples before promoting it as an evidence review.